Results 291 to 300 of about 69,664 (311)

Furosemide and Theophylline

Annals of Internal Medicine, 1985
Excerpt To the editor: The difficulty in maintaining stable around-the-clock serum theophylline concentrations is a well-recognized problem among clinicians caring for patients with asthma (1).
F. Castello, S. Marino, G. Carpentiere
openaire   +2 more sources

Furosemide disposition in cirrhosis

Clinical Pharmacology and Therapeutics, 1982
Furosemide disposition after rapid intravenous injection (80 mg) was studied in 10 normal healthy subjects and eight patients with cirrhosis and ascites. In the cirrhotic patients the elimination half-life was modestly longer (81.0 +/- 8.0 min and 60.2 +/- 5.8 min). This prolongation was not associated with a difference in systemic clearance (156 +/- 7
Robert A. Branch, Roger K Verbeeck, Jean-Pierre Villeneuve, Grant R. Wilkinson, Rashmi V. Patwardhan   +4 more
openaire   +3 more sources

Furosemide-Induced Ototoxicity

Annals of Internal Medicine, 1979
Excerpt The Adverse Drug Reaction Reporting Program of the Division of Drug Experience, Food and Drug Administration (1), has received 29 case reports of deafness associated with the administration...
Kevin L. Gallagher, Judith K. Jones
openaire   +3 more sources

On the fate of furosemide in man

European Journal of Clinical Pharmacology, 1975
35S-furosemide was administered orally (n=7) or i.v. (n=2) to healthy subjects. The average gastrointestinal uptake estimated by comparison of the urinary recovery of label and the areas under the plasma curves after the two routes of administration was 65%.
Björn Lindström, Elisabet Dalen, A. Rosén, Björn Beermann   +3 more
openaire   +3 more sources

Placental transfer of furosemide

Clinical Pharmacology & Therapeutics, 1978
After oral administration of furosemide to 18 pregnant women on the day of delivery, substantial concentrations of the drug were detected in umbilical cord vein plasma as well as in amniotic fluid. The ratio between the furosemide concentrations in maternal vein plasma and in umbilical cord plasma increased with time and approximated unity at 8 to 10 ...
Margaretha Groschinsky-Grind, Björn Lindström, Lars Fåhraeus, Björn Beermann   +3 more
openaire   +3 more sources

Tobramycin-Furosemide Interaction

Drug Intelligence & Clinical Pharmacy, 1984
A 70-year-old, 75-kg white female with a history of congestive heart failure was admitted with a two-week episode of progressive shortness of breath, increased abdominal distension, and ankle edema. Sputum Gram stains revealed gram-negative bacilli, and the patient was started on a loading dose of tobramycin 150 mg (2 mg/kg) over 30 minutes.
Christopher Lyman, David J. Kilarski, Juzar S. Kaka   +2 more
openaire   +3 more sources

Pharmacokinetics of furosemide in neonates

European Journal of Clinical Pharmacology, 1982
The pharmacokinetics of furosemide was evaluated in 12 newborns who received the drug transplacentally, and in 21 neonates who received it directly for therapeutic reasons. In the first group, the apparent plasma half-lives ranged from 96 to 6.8 h with a significant inverse relationship (p less than 0.01) between the gestational age and the elimination
M Broquaire, Paul Vert, P L Morselli, M Legagneur   +3 more
openaire   +3 more sources

Anaphylaxis to intravenous furosemide

Journal of Allergy and Clinical Immunology, 1987
A patient with long-standing hypertension developed urticaria, angioedema, and hypotension within 5 minutes after the intravenous administration of furosemide. Immediate hypersensitivity was documented by positive skin tests to furosemide as well as to related sulfonamide-based drugs.
H. James Wedner, David D. Chaplin, J. Randall Hansbrough   +2 more
openaire   +2 more sources

Reactions to furosemide

American Heart Journal, 1978
S.E. Warren, S.M. Steinberg
openaire   +3 more sources

Clinical Experience with Furosemide

Southern Medical Journal, 1968
GEORGE R. HERRMANN, ROBERT G. GHISELLI, SARA D. CLARK   +2 more
openaire   +3 more sources